Clinical Trial Update: Early Versus Delayed BCG Vaccination of HIV-exposed Infants [Phase 2]

View source ↗

Summary

A phase 2 trial comparing early versus delayed Bacillus Calmette-Guérin vaccination in HIV-exposed infants was completed, with results posted in 2017. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: University of Cape Town | Conditions: HIV Exposure, HIV Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-03-15